Association of Immune Checkpoint Inhibitor Therapy With Survival in Patients With Cancers With MUC16 Variants

This cohort study investigates whether MUC16 variation could be a useful biomarker for immune checkpoint inhibitor (ICI) therapy.

Detalles Bibliográficos
Autores principales: Yu, Yunfang, Lin, Dagui, Li, Anlin, Chen, Yongjian, Ou, Qiyun, Hu, Hai, Yao, Herui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292997/
https://www.ncbi.nlm.nih.gov/pubmed/32530468
http://dx.doi.org/10.1001/jamanetworkopen.2020.5837
_version_ 1783546209934245888
author Yu, Yunfang
Lin, Dagui
Li, Anlin
Chen, Yongjian
Ou, Qiyun
Hu, Hai
Yao, Herui
author_facet Yu, Yunfang
Lin, Dagui
Li, Anlin
Chen, Yongjian
Ou, Qiyun
Hu, Hai
Yao, Herui
author_sort Yu, Yunfang
collection PubMed
description This cohort study investigates whether MUC16 variation could be a useful biomarker for immune checkpoint inhibitor (ICI) therapy.
format Online
Article
Text
id pubmed-7292997
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-72929972020-06-15 Association of Immune Checkpoint Inhibitor Therapy With Survival in Patients With Cancers With MUC16 Variants Yu, Yunfang Lin, Dagui Li, Anlin Chen, Yongjian Ou, Qiyun Hu, Hai Yao, Herui JAMA Netw Open Research Letter This cohort study investigates whether MUC16 variation could be a useful biomarker for immune checkpoint inhibitor (ICI) therapy. American Medical Association 2020-06-12 /pmc/articles/PMC7292997/ /pubmed/32530468 http://dx.doi.org/10.1001/jamanetworkopen.2020.5837 Text en Copyright 2020 Yu Y et al. JAMA Network Open. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Research Letter
Yu, Yunfang
Lin, Dagui
Li, Anlin
Chen, Yongjian
Ou, Qiyun
Hu, Hai
Yao, Herui
Association of Immune Checkpoint Inhibitor Therapy With Survival in Patients With Cancers With MUC16 Variants
title Association of Immune Checkpoint Inhibitor Therapy With Survival in Patients With Cancers With MUC16 Variants
title_full Association of Immune Checkpoint Inhibitor Therapy With Survival in Patients With Cancers With MUC16 Variants
title_fullStr Association of Immune Checkpoint Inhibitor Therapy With Survival in Patients With Cancers With MUC16 Variants
title_full_unstemmed Association of Immune Checkpoint Inhibitor Therapy With Survival in Patients With Cancers With MUC16 Variants
title_short Association of Immune Checkpoint Inhibitor Therapy With Survival in Patients With Cancers With MUC16 Variants
title_sort association of immune checkpoint inhibitor therapy with survival in patients with cancers with muc16 variants
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292997/
https://www.ncbi.nlm.nih.gov/pubmed/32530468
http://dx.doi.org/10.1001/jamanetworkopen.2020.5837
work_keys_str_mv AT yuyunfang associationofimmunecheckpointinhibitortherapywithsurvivalinpatientswithcancerswithmuc16variants
AT lindagui associationofimmunecheckpointinhibitortherapywithsurvivalinpatientswithcancerswithmuc16variants
AT lianlin associationofimmunecheckpointinhibitortherapywithsurvivalinpatientswithcancerswithmuc16variants
AT chenyongjian associationofimmunecheckpointinhibitortherapywithsurvivalinpatientswithcancerswithmuc16variants
AT ouqiyun associationofimmunecheckpointinhibitortherapywithsurvivalinpatientswithcancerswithmuc16variants
AT huhai associationofimmunecheckpointinhibitortherapywithsurvivalinpatientswithcancerswithmuc16variants
AT yaoherui associationofimmunecheckpointinhibitortherapywithsurvivalinpatientswithcancerswithmuc16variants

Ejemplares similares